Finance

Beta
Lists
GXI:FRA
Gerresheimer AG
€25.90
-2.56%
(-0.68) 1D
Jun 5, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for GXI...
Open
€25.76
High
€25.96
Low
€25.76
Mkt. cap
871.70M
Avg. vol.
1.38K
Volume
959.00
Dividend
0.15%
Quarterly dividend
€0.01
Ex-dividend date
Jun 6, 2024
P/E ratio
38.31
52-wk high
€50.90
52-wk low
€14.92
EPS
€0.68
Shares outstanding
31.40M
No. of employees
14K
Open
€25.76
High
€25.96
Low
€25.76
Mkt. cap
871.70M
Avg. vol.
1.38K
Volume
959.00
Dividend
0.15%
Quarterly dividend
€0.01
Ex-dividend date
Jun 6, 2024
P/E ratio
38.31
52-wk high
€50.90
52-wk low
€14.92
EPS
€0.68
Shares outstanding
31.40M
No. of employees
14K
News stories
From sources across the web
About Gerresheimer AG
CEO-
Employees13.5K
Founded1864
HeadquartersDüsseldorf, North Rhine-Westphalia, Germany
SectorHealth care
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Nov 2024
Feb 2025
May 2025
Aug 2025
Revenue
568.87M
520.05M
600.66M
560.68M
Cost of goods sold
387.19M
393.30M
442.82M
421.79M
Cost of revenue
387.19M
393.30M
442.82M
421.79M
Research and development expenses
6.90M
6.12M
3.16M
5.56M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
105.88M
103.17M
105.31M
100.98M
Operating expense
100.54M
111.63M
107.16M
131.51M
Total operating expenses
487.73M
504.94M
549.99M
553.30M
Operating income
81.14M
15.12M
50.67M
7.38M
Other non operating income
1.40M
824.00K
739.00K
337.00K
EBT including unusual items
47.58M
-25.32M
28.78M
-15.01M
EBT excluding unusual items
65.74M
-25.32M
28.78M
-15.01M
Income tax expense
9.29M
-7.83M
11.16M
-2.74M
Effective tax rate
19.52%
30.93%
38.77%
18.26%
Other operating expenses
-12.23M
2.35M
-1.30M
24.96M
Net income
37.04M
-18.01M
17.02M
-12.70M
Net profit margin
6.51%
-3.46%
2.83%
-2.27%
Earnings per share
1.63
0.46
0.90
0.69
Interest and investment income
2.09M
1.27M
947.00K
627.00K
Interest expense
-17.46M
-42.53M
-23.58M
-23.36M
Net interest expenses
-15.38M
-41.26M
-22.63M
-22.73M
Depreciation and amortization charges
-
-
-
-
EBITDA
110.88M
82.31M
117.72M
74.08M
Gain or loss from assets sale
6.16M
164.00K
-41.00K
-49.00K
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more